JPM US Growth D (acc) USD |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | 40.4 | 26.1 | -22.6 | 29.3 | 14.8 | |
+/-Cat | 16.3 | -3.9 | 3.1 | -0.4 | 5.1 | |
+/-Idx | 15.6 | -9.6 | 4.8 | -5.9 | 4.4 | |
Category: US Large-Cap Growth Equity | ||||||
Benchmarks: Morningstar US LM Brd Growt... |
Key Stats | ||
NAV 03/05/2024 | USD 32.69 | |
Day Change | 1.85% | |
Morningstar Category™ | US Large-Cap Growth Equity | |
ISIN | LU0119065240 | |
Fund Size (Mil) 03/05/2024 | USD 3391.23 | |
Share Class Size (Mil) 03/05/2024 | USD 121.23 | |
Max Initial Charge | - | |
Ongoing Charge 06/12/2023 | 2.48% |
Investment Objective: JPM US Growth D (acc) USD |
To provide long-term capital growth by investing primarily in a growth style biased portfolio of US companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Giri Devulapally 20/12/2010 | ||
Joseph Wilson 17/02/2017 | ||
Inception Date 20/10/2000 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
Russell 1000 Growth NR USD | Morningstar US LM Brd Growth NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPM US Growth D (acc) USD | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 9.59 |
NVIDIA Corp | Technology | 7.87 |
Amazon.com Inc | Consumer Cyclical | 7.11 |
Meta Platforms Inc Class A | Communication Services | 6.14 |
Eli Lilly and Co | Healthcare | 5.40 |
Increase Decrease New since last portfolio | ||
JPM US Growth D (acc) USD |